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ABSTRACT
ObjectivesToseewhethertellingpeerreviewersthattheir
signed reviews of original research papers might be
posted on the BMJ’s website would affect the quality of
their reviews.
Design Randomised controlled trial.
Setting A large international general medical journal
based in the United Kingdom.
Participants541 authors,471 peer reviewers,12 editors.
Intervention Consecutive eligible papers were
randomised either to have the reviewer’s signed report
made available on the BMJ’s website alongside the
publishedpaper(interventiongroup)ortohavethereport
made available only to the author—the BMJ’s normal
procedure(controlgroup). The interventionwas the actof
revealing to reviewers—after they had agreed to review
but before they undertook their review—that their signed
report might appear on the website.
MainoutcomemeasuresThemainoutcomemeasurewas
the quality of the reviews, as independently rated on a
scaleof1to5usingavalidatedinstrumentbytwoeditors
and the corresponding author. Authors and editors were
blind to the intervention group. Authors rated review
quality before the fate of their paper had been decided.
Additional outcomes werethe timetaken to completethe
review and the reviewer’s recommendation regarding
publication.
Results 558 manuscripts were randomised, and 471
manuscripts remained after exclusions. Of the 1039
reviewersapproachedtotakepartinthestudy,568(55%)
declined. Two editors’ evaluations of the quality of the
peer review were obtained for all 471 manuscripts, with
the corresponding author’s evaluation obtained for 453.
There was no significant difference in review quality
between the intervention and control groups (mean
difference for editors 0.04, 95% CI −0.09 to 0.17; for
authors 0.06, 95% CI −0.09 to 0.20). Any possible
difference in favour of the control group was well below
the level regarded as editorially significant. Reviewers in
the intervention group took significantly longer to review
(meandifference25minutes,95%CI3.0to47.0minutes).
Conclusion Telling peer reviewers that their signed
reviews might be available in the public domain on the
BMJ’s website had no important effect on review quality.
Although the possibility of posting reviews online was
associated with a high refusal rate among potential peer
reviewers and an increase in the amount of time taken to
write a review, we believe that the ethical arguments in
favour of open peer review more than outweigh these
disadvantages.
INTRODUCTION
Traditionalpeerreviewforscientificandmedicaljour-
nals has major flaws. Although the peer reviewer
knows the identity of the author of the manuscript
being assessed, the author doesn’t know the identity
of the peer reviewer. Over recent years this form of
peer review has come under increasing criticism, lar-
gely for its lack of accountability.
12 Unscrupulous
reviewers can delay or prevent the publication of
workwithwhichtheydisagree,orpromoteinappropri-
atelytheworkoflikemindedresearchers.
34Worsestill,
reports exist of anonymous reviewers appropriating
ideas and words from the manuscripts they have been
reviewing.
5
At an assembly to discuss reviewer anonymity orga-
nised in 1994 by the journal Cardiovascular Research,
consensus emerged among commentators that open
peer review was the way ahead.
346Part of the impetus
for this move towards greater openness has been the
belief that science needs to catch up with the rest of
the world, where transparency of decision making is
becomingthenorm.Forimportantdecisionsthataffect
us, we now expect to know who made them and how
they arrived at their decision. “The editors, assisted by
the reviewers, are judges,” says Drummond Rennie, a
supporter of open peer review.
5 “We have an ample
history to tell us that justice is ill served by secrecy.”
A series of studies has examined whether reducing
the asymmetry between reviewers and authors affects
the quality of reviewers’ reports. An early randomised
trial indicated that blinding peer reviewers to the iden-
tity of authors would lead to better reports,
7 but two
larger studies have since failed to confirm this.
89
Researchers have therefore turned their attention to
the effects of being as open with reviewers’ as with
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of randomised controlled trials testing the effects of
incremental increases in openness on the quality of
peer reviewers’ reports. In previous studies we found
thatalthoughrevealingtheidentityofthereviewertoa
co-reviewer had a small, editorially insignificant but
statistically significant beneficial effect on the quality
of the review,
8 revealing the identity of the reviewer
to the author had no significant effect.
10
No trials have been published on the effect of peer
reviewers being told that their review will be available
toreaders.Althoughsomejournalsnowsharereviewers’
identities with authors, as far as we can tell the only pub-
lisher to reveal them to readers is BioMed Central. A
recently reported survey found only three of 56 journals
had what was described as open peer review.
11
Although the peer review process has changed and
reviewers for some journals have become used to more
openness, evidence about the effect of opening review
further is still required. Trust in the processes of science
is still relevant, and reluctance remains, at least in some
areas of medical research, to fully open up peer
review.
1213 This study marks the third step in the
sequence of trials at the BMJ. We set out to investigate
the effects of reviewers’ foreknowledge that their signed
review might be shared not just with co-reviewers and
authors, but also with any interested reader.
METHODS
This study was designed to determine whether
reviewers who knew that their signed reviews might
be posted onthe BMJ’s websitewould produce reports
whose quality differed from those of reviewers who
knew the reports would be shared only with authors.
Duringthestudy,thejournalfolloweditsusualprac-
tice of seeking external peer review only for the min-
ority of manuscripts that editors regard as having a
reasonable chance of acceptance. Consecutive
research manuscripts chosen by editors for external
review between November 1999 and July 2000 were
eligible for inclusion. Four potential reviewers of the
paper’s clinical content were selected by one of the
BMJ’s 12 editors, after which simple randomisation of
manuscripts into either the intervention or the control
group was performed using a random number genera-
tor.Detailsofthestudyweresenttothecorresponding
author, who was asked to consent to the inclusion of
their paper in the study.
The first of the editors’ four potential reviewers was
contacted with details of the study, including the title
and author of the paper, and asked whether he or she
was willing to review the paper. At this point, no infor-
mation was given about the study arm into which the
paperhadbeenallocated.Ifthefirstreviewerdeclined,
the next was contacted, continuing until a consenting
reviewer was found. If none of the four potential
reviewers consented, the paper was excluded.
Allocationwasrevealedwhenthefullpaperwassent
to the peer reviewer. The intervention was therefore
theactofrevealingtoreviewersthattheirsignedreport
might appear on the BMJ’s website. Reviewers in both
groups were also sent a questionnaire asking for their
recommendation regarding publication and the time
taken to review. Questionnaire responses were not
shared with the authors.
Theresponsibleeditorwasaskedtoassessthequality
of the review on a Likert scale of 1 to 5 by using a vali-
datedreviewqualityinstrument(RQI).
14Asecondedi-
tor, selected from the other 11 editors using a random
number generator, also independently assessed the
quality of the review. Editors were blinded throughout
to the group allocation. The author was sent a copy of
the review, told that a decision on the manuscript had
not yet been reached, and asked to assess the qualityof
the review using the same instrument.
A mean total score was calculated from the seven
questions on the RQI. The primary outcome measure
was editors’ scores calculated as the mean for the two
editors.Thesecondaryoutcomewasthereportedtime
taken to review.
According to previous research, the standard devia-
tioninqualityscoresisabout1.2.
81014Onthisbasis,the
minimum difference between study groups regarded
as editorially significant was a difference of 0.4 (10%
of the maximum possible difference for a Likert scale
of 1 to 5). With α=0.05 and β=0.1, 190 manuscripts in
Table 1 |Reasons for post-randomisation exclusion of
manuscripts
Intervention (n (%)) Control (n (%))
All reviewers declined 23 (58) 31 (66)
Author did not consent 9 (23) 8 (17)
Not eligible 5 (13) 2 (4)
Review too late 2 (5) 5 (11)
Other 1 (3) 1 (2)
Total 40 (100) 47 (100)
Allocated to control group (n=293)
  Received control intervention (n=246)
  Did not receive control intervention (n=47):
    All four reviewers declined (n=31)
    Authors did not consent (n=8)
    Review arrived too late (n=5)
    Not eligible (n=2)
    Other (n=1)
Allocated to intervention group (n=265)
  Received intervention (n=225)
  Did not receive intervention (n=40):
    All four reviewers declined (n=23)
    Authors did not consent (n=9)
    Not eligible (n=5)
    Review arrived too late (n=2)
    Other (n=1)
Analysed by editors (n=246) 
Analysed by authors (n=240) 
  Excluded from analysis (n=6) 
  Authors failed to provide evaluation (n=6)
Analysed by editors (n=225) 
Analysed by authors (n=213) 
  Excluded from analysis (n=12) 
  Authors failed to provide evaluation (n=12)
Assessed for eligibility (n=558)
Enrolment
Randomised (n=558)
Lost to follow-up (n= 0) Lost to follow-up (n= 0)
Excluded (n=0)
Randomisation and analysis of eligible manuscripts
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this number to allow for exclusions and non-return of
evaluations.
When accepted papers in the intervention group
were ultimately published, the reviewer’s signed com-
ments were posted on the BMJ’s website alongside the
relevant paper. In addition, we posted the manuscript
as originally received, our editorial committee’s com-
ments (if any), our statistician’s comments (if any),and
theauthor’sexplanationofhowheorshehadchanged
their original manuscript in the light of these com-
ments. These constituted the paper’s entire “prepubli-
cationhistory.”Forrejectedpapers,nodocumentation
was posted on the website.
Comparisons of outcome measures were made
using χ
2 tests and paired and unpaired Student’s t
tests. Tests for interaction were done using analysis of
variance. Agreement between editors was assessed
usingweightedκstatistics.Subgroupanalysisusedstra-
tification by ultimate acceptance or rejection, and
reviewer recommendation of acceptance or rejection.
Data collection and analysis were performed using
MicrosoftAccess,MicrosoftExcel,andStatastatistical
software (version 11).
RESULTS
Recruitment and randomisation
All558eligiblemanuscriptswererandomisedtoeither
the intervention group (n=265) or the control group
(n=293; figure). A total of 87 manuscripts (40 in the
intervention group and 47 in the control group) were
excluded after randomisation (table 1). The most
common reason for exclusion was the failure of any
ofthefourselectedreviewersinvitedtoagreetoreview
the manuscript. The outcomes of the requests for par-
ticipation made to potential reviewers of the 525
papers remaining after exclusions (other than a failure
to identify a reviewer after four attempts) are given in
table 2. Altogether, 1039 reviewers were approached
and 471 (45%) agreed to participate (225 in the inter-
vention group and 246 in the control group). Reasons
why first reviewers declined are given in table 3. No
reviewers who had agreed to participate subsequently
declined after the group allocation had been revealed.
Evaluations were received from two editors for all
471 manuscripts included in the study and from the
corresponding author for 453 (96%) papers (213 in
the intervention group and 240 in the control group).
Sixteen (3%) reviewers did not make a recommenda-
tion regarding publication, and 15 (3%) did not say
how long the review took.
Acceptance
Allocation to the intervention group had no significant
effect on the likelihood that reviewers would recom-
mend acceptance (135/219 (62%) v 136/237 (57%); dif-
ference4%,95%CI−5%to13%)orthatthepaperwould
ultimately be accepted for publication (50/225 (22%) v
67/246 (27%); difference −5%, 95% CI −13% to 3%).
Effect of intervention on review quality
Forewarningreviewersthattheirsignedreviewsmight
be published alongside the paper (the intervention)
had no discernible effect on the overall quality of
their reviews (table 4).
Difference between editors’ and authors’ evaluations of
review quality
Authors gave lower scores to reviews than editors, but
the difference between the mean scores, 0.26, was less
than 0.4, the minimum difference regarded as edito-
rially significant. The 95% confidence interval (0.19
to 0.34) also excluded a difference of 0.4, although it
was highly statistically significant. When the reviewer
recommended rejection (although this was not
revealed to the author), the author and editor had
markedlydifferentassessmentsofquality,withauthors
scoring reviews on average 0.6 (95% CI 0.48 to 0.72)
points lower than editors (P<0.0001). These author-
editor differences were consistent between the inter-
vention and control groups.
Effect of intervention on time taken to write review
Reviewers in the intervention group took on average
25 minutes longer over their review than reviewers in
the control group (182 minutes (SD 135.2) v 157 (SD
101.9) minutes; table 4). Reviewers in the intervention
grouptooksignificantlylongerthancontrolsoverreports
onpaperseventuallyaccepted(41minutes,95%CI2.0to
78.7), but the difference was smaller and non-significant
for papers that they recommended accepting
(22 minutes, 95% CI −7.5 to 52.2); that is, those for
which reviews would more likely be posted online.
Table 2 |Number of reviewers invited before a reviewer willing to participate in the study was
found
Intervention Control
Invited
(n)
Accepted
(n)
Acceptance rate
(%)
Invited
(n)
Accepted
(n)
Acceptance rate
(%)
One 248 125 50 277 138 50
Two 123 45 37 139 52 37
Three 78 39 50 87 39 45
Four 39 16 41 48 17 35
Total 488 225 46 551 246 45
These figures comprise papers included in the study (225 in the intervention group and 246 in the control
group) and papers that were excluded because of failure to find a reviewer (23 in the intervention group and 31
in the control group).
Table 3 |Reasons for first reviewers declining to provide a review
Papers included
in the study (n (%))
Papers excluded after four attempts
to find a reviewer (n (%))
Too busy 93 (45) 21 (39)
No reply 58 (28) 16 (30)
Notinreviewer’sfield 16 (8) 7 (13)
Conflict of interest 16 (8) 1 (2)
Other 25 (12) 9 (17)
Total 208 (100) 54 (100)
These figures comprise papers included in the study (225 in the intervention group and 246 in the control
group) and papers that were excluded because of failure to find a reviewer (23 in the intervention group and 31
in the control group). “Other” category includes nine papers in the study and five excluded papers where the
reviewer did not give a reason for declining.
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Of the 115 papers formally accepted for publication,
50wereintheinterventiongroup.Theentireprepubli-
cationhistory(asdefinedintheMethodssection)of32
of these papers has been published on the BMJ’s web-
site alongside the accepted paper (see web table A).
DISCUSSION
Warningpeerreviewersthattheirsignedreportsmight
be published on the BMJ’s website alongside the
accepted paper did not noticeably affect the quality of
reports compared with those obtained under the jour-
nal’s usual procedure. Editors’ and authors’ assess-
ments of quality were very similar, except for reviews
of papers where reviewers had recommended
rejection. As a previous study has found, authors rate
such reviews of lower quality.
15
Although their reviews were not rated as higher
quality, peer reviewers in the intervention group over-
all took significantly longer to assess manuscripts than
did reviewers in the control group. These reviewers
might have been expected to spend notably more
time, and give higher quality reports, on papers that
they were recommending for acceptance because
their reviews were more likely to be shared with the
world.However,anydifferenceswererelativelysmall.
Comparison with other studies
Two previous studies at the BMJ have come up with
similar findings to those of this study: opening up the
process of peer review neither greatly improved the
quality of the reviewers’ reports nor, reassuringly,
madeitworse.
810Anotherstudyofthequalityofsigned
and unsigned reviews found a statistically, but not edi-
torially, significant improvement in the quality of
signed versus unsigned reviews.
16
Strengths and limitations of study
In this study we randomised all eligible papers and
used a validated instrument to assess review quality.
14
One possible explanation for our failure to find differ-
ences between the intervention and control groups
couldhavebeenpoorsensitivityoftheRQI.However,
the instrument has successfully detected differences in
review quality in several randomised studies.
8101617
The rate of refusal of reviewers to participate in the
study was high at 55%. All eligible papers were entered
intothestudy,sotherewasnowayofcalculatingaback-
ground refusal rate over the course of the study. How-
ever, weknowfromour previous studiesofpeer review
thatmorereviewerssaytheywouldrefusetotakepartin
atrialofahypotheticalinterventionthanactuallyrefuse
when the intervention is formally introduced.
In this study, the relatively high rate of reviewers’
refusaltoparticipateandthe failureoftheintervention
toproducebetterreportsbegsthequestionofwhether,
as in ordinary clinical trials, participants differ from
those not in the trial. Our intervention could be seen
as having two stages, with the first, and arguably the
most important, being the selection of reviewers who
were happy for their signed reports to be published.
Only these individuals could be randomised, so this
selection process may itself have picked out reviewers
who would provide more careful reports. Informing
this subset of potential reviewers that their review
would be published online with the paper might have
had much less effect on the quality of reviews than it
might for reviewers in general. If the policy were to be
adopted by a journal, it might mean that the pool of
reviewers would be reduced.
Reviewers who knew that their report might be
posted online spent longer on the task than those in
the control group, so adopting open peer review
might result in the process feeling even more arduous
to reviewers than it currently does. This is a concern
Table 4 |Effect on review quality and time taken to review of forewarning reviewers that their
signed reviews might be published online
Intervention(mean
(SD))
Control (mean
(SD)) Difference (95% CI)
Total
Editors’ assessment (mean total score) 3.40 (0.73) 3.36 (0.69) 0.04 (−0.09 to 0.17)
n 225 246
Authors’ assessment (mean total score) 3.16 (0.77) 3.10 (0.80) 0.06 (−0.09 to 0.20)
n 213 240
Reviewers’ time taken (minutes) 182 (135.2) 157 (101.9) 25* (3.0 to 47.0)
n 219 237
Accepted papers† †
Editors’ assessment (mean total score) 3.50 (0.66) 3.21 (0.77) 0.29* (0.02 to 0.55)
n5 0 6 7
Authors’ assessment (mean total score) 3.33 (0.71) 3.36 (0.74) 0.03 (−0.29 to 0.25)
n4 9 6 7
Reviewers’ time taken (minutes) 169 (115.9) 128 (78.2) 41* (2.0 to 78.7)
n4 9 6 3
Rejected papers
Editors’ assessment (mean total score) 3.37 (0.74) 3.42 (0.65) −0.05(−0.19to0.10)
n 175 179
Authors’ assessment (mean total score) 3.11 (0.77) 3.00 (0.81) 0.11 (−0.06 to 0.27)
n 164 173
Reviewers’ time taken (minutes) 186 (140.3) 168 (107.5) 18 (−8.3 to 44.8)
n 170 174
Papers recommended by reviewers for acceptance‡ ‡
Editors’ assessment (mean total score) 3.44 (0.73) 3.34 (0.72) 0.10 (−0.07 to 0.27)
n 135 136
Authors’ assessment (mean total score) 3.39 (0.66) 3.38 (0.70) 0.01 (−0.15 to 0.18)
n 126 133
Reviewers’ time taken (minutes) 186 (134.2) 164 (114.9) 22 (−7.6 to 52.2)
n 135 136
Papers recommended by reviewers for rejection‡ ‡
Editors’ assessment (mean total score) 3.32 (0.74) 3.38 (0.65) −0.06(−0.27to0.14)
n 83 101
Authors’ assessment (mean total score) 2.81 (0.78) 2.72 (0.75) 0.09 (−0.14 to 0.32)
n8 0 9 8
Reviewers’ time taken (minutes) 166 (114.4) 148 (80.7) 18 (−10.8 to 48.1)
n 83 101
18 reviews did not have an author’s evaluation.
*P<0.05.
†Two papers returned to author for revision are included.
‡Indicates response given in questionnaire.
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ponent in the peer review process.
Disclosure of a reviewer’s identity has, however,
brought substantial benefits. Posting the entire prepu-
blication history of accepted papers on the journal’s
website has turned our practice of peer review from
what wastraditionally a “black box” into a transparent
process.PotentialauthorscanseeexactlywhattheBMJ
meansbypeerreviewandcanmakeaninformeddeci-
sion about whether our version adds enough value to
justify sending their papers to us. Posting reviewers’
signed comments alongside the accepted paper
means that reviewers can now receive full credit for
their contribution to science.
Opponents of open peer review cite two main con-
cerns. The first is that open peer review may provide
less critical, and therefore less useful, reports. Although
our validated instrument to measure quality doesn’t
include “criticality” as one of its dimensions, during the
validation process we found good correlation between
the instrument’ss c o r e sa n de d i t o r s ’ overall assessment
of review quality.
14 In this study, as in previous studies,
reviewers in the intervention group were not signifi-
cantly more likely to recommend acceptance.
810
The second concern relates to the possible negative
effects of open peer review on relationships among
individuals working in the same field. In response to
such fears, the BMJ set up a system of adverse event
reporting that used a “yellow card,” which was routi-
nely sent out with papers for review. Reviewers and
authors were informed of the existence of this system
of reporting and were asked to use the yellow card to
notify the editor, in confidence, of any adverse events
occurring as a direct result of our policy of open peer
review. In nearly five years of the system’s operation,
only one adverse event was reported, and this event
did not occur in the context of any of our studies.
One factor that may have militated against this pro-
blem is that potential reviewers in general medicine
come from a very wide pool, so internecine battles
are less likely than in smaller research communities.
A third, subsidiary, concern relates to the extra time
required to do carefully constructed reviews suitable
for wide scrutiny. The question is whether the benefits
ofopenpeerreviewaresufficienttooutweighthisprice
of extra time and the associated reluctance of some
reviewers to participate.
Conclusions and policy implications
The results of our study suggest that extending open
peer review to include sharing reviewers’ signed
reportswiththeworldatlargeisfeasibleatalargemed-
ical journaland doesnot adverselyaffect the quality of
these reports, nor does it improve it by any notable
amount. It may, however, reduce the number of will-
ing reviewers and increase the time taken to review.
The BMJ is committed to opening up its peer review
process, providing that it can achieve this without
damaging quality. We believe that the ethical argu-
ments in favour of open peer review outweigh any
practical concerns.
We would like to see similar studies undertaken at
other large journals to establish the generalisability of
our results. We would also urge smaller and more spe-
cialist journals to consider doing similar studies to
ascertain whether our findings are applicable in fields
other than general medicine.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Openness and transparency are areas of concern in medical research, especially involving
medicines
Secrecy and lack of accountability are serious flaws of traditional peer review, but most
scientific journals are reluctant to address these concerns
Revealing the identity of a reviewer to a co-reviewer or to the author of the reviewed paper
does not adversely affect the quality of a review
WHAT THIS STUDY ADDS
Telling peer reviewers that their signed review might appear online alongside the published
paper does not affect the quality of their review
Reviewers who know that their signed review might appear online alongside the published
paper take significantly longer to complete their review
Reviewers, although not authors, are reluctant to participate in an experiment of very open
peer review
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